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ABSTRACT
Objectives: We tested the hypothesis that there is a
positive association between maternal body mass index
(BMI) and the concentration of appetite-regulating
hormones leptin, insulin, ghrelin and resistin in breast
milk. We also aimed to describe the change in breast
milk hormone concentration within each feed, and over
time.
Setting: Mothers were recruited from the postpartum
ward at a university hospital in London. Breast milk
samples were collected at the participants’ homes.
Participants: We recruited 120 healthy, primiparous,
breastfeeding mothers, aged over 18 years. Mothers
who smoked, had multiple births or had diabetes were
excluded. Foremilk and hindmilk samples were
collected from 105 women at 1 week postpartum and
92 women at 3 months postpartum.
Primary and secondary outcome measures: We
recorded maternal and infant anthropometric
measurements at each sample collection and measured
hormone concentrations using a multiplex assay.
Results: The concentration of leptin in foremilk
correlated with maternal BMI at the time of sample
collection, at 7 days (r=0.31, p=0.02) and 3 months
postpartum (r=0.30, p=<0.00). Foremilk insulin
correlated with maternal BMI at 3 months postpartum
(r=0.22, p=0.04). Breast milk ghrelin and resistin were
not correlated with maternal BMI. Ghrelin
concentrations at 3 months postpartum were increased
in foremilk compared with hindmilk (p=0.01).
Concentrations of ghrelin were increased in hindmilk
collected at 1 week postpartum compared with
samples collected at 3 months postpartum (p=0.03).
A trend towards decreased insulin concentrations in
hindmilk was noted. Concentrations of leptin and
resistin were not seen to alter over a feed.
Conclusions: A positive correlation between
maternal BMI and foremilk leptin concentration at
both time points studied, and foremilk insulin at
3 months postpartum was observed. This may have
implications for infant appetite regulation and
obesity risk.
INTRODUCTION
The functions of breast milk are varied.
While its main function is to provide infant
nutrition, breast milk also contains many bio-
active factors, including growth factors and
hormones. These have the potential to affect
infant development.1 Increasing evidence sug-
gests that long-term programming of adult
health occurs during gestation and early neo-
natal life. In addition, the nutrition received
during this time appears to be particularly
important in relation to determining an
infants’ risk of later-life obesity.2
It has been hypothesised that breast milk
may act as a metabolic messenger between
mother and infant, with composition inﬂuen-
cing infant appetite and growth. Appetite-
regulating hormones have been identiﬁed in
breast milk, and it is suggested that these
may also inﬂuence infant appetite and
appetite-regulatory pathways.3 These observa-
tions may partially explain the increased risk
of obesity found in infants of mothers of a
higher body mass index (BMI),4 as in adult
Strengths and limitations of this study
▪ Largest study describing the concentration of
appetite-regulating hormones in foremilk and
hindmilk.
▪ Longitudinal assessment of changes in hormone
concentrations.
▪ Standardisation of sample collection, with add-
ition of protease inhibitors to protect hormones
against proteolytic degradation.
▪ No follow-up of the infants to establish whether
there were any associations between the concen-
trations of these hormones in breast milk and
the subsequent likelihood of infant overweight/
obesity.
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serum the concentration of these hormones correlates
with adiposity.5–8 Furthermore, a number of studies have
suggested breast feeding, in comparison with formula
feeding, protects infants against obesity in later life,9–11
though other studies have not observed this associ-
ation.12 If breast feeding is capable of protecting infants
against obesity in later life, this may potentially be par-
tially explained by the presence of these
appetite-regulating hormones in breast milk.
Leptin is a peptide hormone synthesised by the white
adipose tissue and displays an anorexigenic or appetite-
suppressing effect.13 14 Obese individuals have higher
concentrations of leptin in their circulation.15
Therefore, infants exposed to increased concentrations
of this hormone may have a reduced appetite. Insulin
has previously been identiﬁed in breast milk16 and has
also been demonstrated to display anorexigenic
effects.17 Conversely, ghrelin, also a peptide hormone,
has been shown to display appetite-stimulatory effects.18
Resistin, a relatively recently discovered adipokine, is sig-
niﬁcantly increased in concentration in obese indivi-
duals and has been demonstrated to interfere with the
action of insulin.19
Foremilk and hindmilk hormone concentrations were
investigated to establish whether they changed over the
course of a feed, potentially acting as a satiety factor.
This effect has been studied previously; the concentra-
tion of glucagon-like peptide-1 was found to be higher
in hindmilk than foremilk,20 while leptin was not
observed to alter in concentration between foremilk and
hindmilk.20 Similarly, Karatas et al21 have investigated the
concentration of ghrelin and leptin in foremilk and
hindmilk samples. Ghrelin was observed to have lower
concentrations in hindmilk in comparison with foremilk.
Conversely, leptin was seen to have higher concentra-
tions in hindmilk; however, this observation was not stati-
stically signiﬁcant.
Previous research has also investigated the changes in
concentration of some of these hormones over lactation.
Leptin has been shown to decrease in concentration
over the 5-year postpartum.22
In order for these hormones to inﬂuence infant appe-
tite, they must ﬁrst be absorbed into the infant circula-
tion and remain biologically active. Previously, ghrelin
has been shown to be present in breast milk and asso-
ciated with the quantity of ghrelin in infant circulation,
suggesting it is transferred from breast milk to infant cir-
culation.23 Similarly, animal studies have identiﬁed that
leptin is able to cross into the infant circulation from
breast milk, suggesting milk-derived leptin may have an
appetite-regulatory role.24 Further evidence has shown
that breast milk leptin may actively inﬂuence infant
appetite, being negatively associated with infant weight
gain and BMI.25 26 Insulin has also been shown to enter
the circulation from the gut in animal models27 and has
been associated with infant obesity risk in humans.28
We undertook a longitudinal cohort study to assess the
concentration of the appetite-regulating hormones
leptin, insulin, ghrelin and resistin, in relation to mater-
nal BMI and to describe the changes in breast milk
hormone concentration within each feed, and over
time.
MATERIALS AND METHODS
Cohort selection criteria
Mothers were recruited from the postnatal ward at
Chelsea & Westminster NHS Foundation Trust Hospital
in West London. Formal enrolment took place following
informed, written maternal consent. Mothers from
across the booking BMI range were recruited, with an
attempt to ensure even representation of mothers across
the BMI categories 18.5–24.9 and >25 kg/m2. Only
healthy, primiparous, breastfeeding mothers, aged over
18 years and their healthy, term infants, with a gesta-
tional age of 37 weeks and above were included in the
study. Mothers who smoked, had multiple births or who
were taking prescription drugs inﬂuencing lactation, as
well as mothers with diabetes were excluded.
Sample size
We calculated a sample size of 84 provided 80% power
to detect a correlation between breast milk leptin and
maternal BMI, with an r value of 0.25 (5% signiﬁcance,
two-sided test). In order to detect a correlation between
breast milk insulin and maternal BMI, we calculated we
would require a sample size of 104 individuals, providing
80% power (r value of 0.25, 5% signiﬁcance, two-sided
test). Insufﬁcient data are available to compute a power
calculation for either ghrelin or resistin.
Collection of demographic data
We collected detailed demographic and clinical data
from each participant on enrolment. These included
maternal age, race and BMI (prepregnancy, booking
and current BMI). We also recorded data on infant
characteristics including sex, mode of delivery and gesta-
tional age at delivery. Maternal and infant anthropomet-
ric information was again collected at 1 week and
3 months postpartum.
Anthropometric measurements
We obtained maternal booking weight and height from
medical records. Mothers were asked to recall their pre-
pregnancy weight. Body weight was measured at the
time of each sample collection using a Seca 877 Floor
Scale (Seca, Hamburg, Germany), with mother–infant
weight function, accurate to within 0.01 kg.
Infant crown to heel length (cm) was measured using
a board with a sliding footboard (Rollametre: Raven
Equipment Ltd, Dunmow, Essex, UK). Head circumfer-
ence was measured using a measuring tape between the
eyebrows and the hairline and round the occipital prom-
inence at the back of the head.
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Breast milk collection
Breast milk samples were collected at 1 week and
3 months postpartum, if the mother was still breast
feeding. Samples were collected at the participants’
homes by a research midwife using a Lactaline breast
milk pump (Ameda, Stone, UK), donated by Central
Medical Supplies (Central Medical Supplies, Leek, UK),
into breast milk collection bottles, donated by Sterifeed
(Sterifeed, Cullompton, UK).
Mothers were asked not to feed their infants, or
express breast milk, from the breast from which they
planned to donate from for an hour prior to sample col-
lection. The baby could be fed during this time from
the opposite breast, if hungry. For collection, mothers
were asked to express a 15 mL sample prior to the start
of suckling, marked as foremilk. The baby was then
placed on the breast, and after feeding, another sample
of 5 mL was collected, marked as hindmilk. To control
for diurnal changes in breast milk composition, collec-
tion was standardised to between 10:00 and 13:00.
Samples obtained at participants’ homes were then
transferred to the laboratory and stored at −80°C.
Breast milk sample preparation for analysis
Received samples were aliquoted and protease inhibitors
were added (4-(2-aminoethyl)-benzenesulfonyl ﬂuoride
(AEBSF) at 2 mM, aprotinin at 0.3 μM, bestatin at
130 μM, E-64 at 14 mM, leupeptin at 1mM and EDTA at
1 mM (Sigma-Aldrich, UK)) to prevent the degradation
of peptide hormones present in the breast milk; 20 μL
of this was added to each sample.
Breast milk samples were ﬁrst centrifuged at 20 000×g
at 4°C for 10 min to remove the lipid fraction, which was
removed using a sterile pipette tip, enabling collection
of the lower aqueous fraction for analysis.
Multiplex assay of breast milk hormone composition
The concentrations of the hormones leptin, insulin,
ghrelin and resistin in the aqueous fraction of breast
milk were measured. Samples were analysed in duplicate
in a randomised run order using a Bio-Plex Pro human
diabetes immunoassay (Bio-Rad, USA), in accordance
with manufacturer’s instructions. This analytical plat-
form employs ﬂuorescently dyed beads, each with a
distinct colour code or spectral address to permit discrimi-
nation of individual tests within a multiplex suspension.
Brieﬂy, samples were centrifuged at 10 000×g at 4°C for
10 min to remove particulates, and 50 μL of sample was
incubated with the multiplexed magnetic beads for
1 hour at room temperature, alongside manufacturer-
provided reference samples. The beads were washed and
incubated with analyte-speciﬁc secondary antibodies, fol-
lowed by incubation with a streptavidin–phycoerythrin
detecting agent. Hormone concentrations were measured
using a Bio-Plex MAGPIX Multiplex Reader (Bio-Rad,
USA) and Bio-Plex Manager V. 6.1 software. Representative
assay performance metrics for the hormones measured are
found in table 1.
Whole breast milk samples were also investigated for
their fat concentration using mid-infrared spectroscopy.
Statistics
Data were analysed using SPSS V.22 (IBM, Armonk,
New York, USA). Data collected were assessed for
normality of distribution using histograms and quantile–
quantile (Q–Q) plots; as the data were non-normally dis-
tributed, natural log transformation was applied to the
data, and histograms and Q–Q plots were replotted to
establish normality of distribution, after which parametric
tests were used to investigate the data collected. Natural
log-transformed data were used for Pearson correlation
and regression models, and non-log-transformed data
were used for Spearman correlation. Associations between
hormone concentration and maternal BMI were analysed
with correlation and regression. Results before and after
adjusting for potential confounders were very similar
(adjustments made for maternal age, maternal education
(measured as years of education post age 11), maternal
weight change (measured between recruitment and 7 days
postpartum and 7 days and 3 months postpartum) and
maternal ethnicity (categorised as Caucasian, Asian and
mixed race)). To compare the concentrations of hor-
mones against one another, repeated-measures analysis
of variance was used. Samples with concentrations below
the limit of detection were excluded from the analysis.
p Values ≤0.05 were considered signiﬁcant.
RESULTS
Cohort characteristics
Descriptive statistics of the mothers and infants in this
cohort are shown in table 2. The average maternal age
was 34, with a range from 23 to 46 years, and an average
height was 166 cm. Of the mothers recruited, 3% were
underweight at booking (BMI<18.5, n=4), 73% were of
normal weight (18.5–24.9, n=87), 19% were overweight
(25–29.9, n=23) and 5% were obese (>30, n=6).
Table 1 Assay performance, as determined by manufacturer. Lower limit of quantification (LLOQ), upper limit of
quantification (ULOQ), limit of detection (LOD), coefficient of variation (%CV)
Hormone LLOQ (pg/mL) ULOQ (pg/mL) LOD (pg/mL) Intra-assay (%CV) Intra-assay (%CV)
Ghrelin 16.6 8502 1.2 4 2
Insulin 1.7 3541 1 3 5
Leptin 11.5 128 107 3.1 3 4
Resistin 2.3 4739 1.3 3 4
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The majority of mothers lost weight from the 1-week
to 3-month time point, resulting in a drop in the
average BMI value of mothers at 3 months postpartum.
In addition to this, there was a dropout of several
mothers from the study. In total, 25 mothers withdrew
from the study. The number of mothers who withdrew,
the reason and mean maternal BMI are included in the
online supplementary information table S1.
The majority of women withdrew from the study at the
1-week time point due to no longer wishing to partici-
pate in the study, while at 3 months postpartum, the
majority of women withdrew as they had stopped breast
feeding. Analysis of the population who withdrew at
3 months revealed that these mothers were more likely
to be overweight/obese than mothers who did not with-
draw. Of the normal-weight mothers, 15% withdrew
(74/87), while of the overweight and obese mothers,
25% (18/24) and 66% (4/6), respectively, withdrew.
Mothers who withdrew were also less likely to be univer-
sity educated, Pearson χ2=4.4, p=0.03.
Sample analysis
A total of 369 samples were available for statistical ana-
lysis. The mean concentration of hormones is shown in
table 3. For ghrelin, 43 samples were below the limit of
detection, while 3, 1 and 4 samples were below the limit
of detection for leptin, insulin and resistin, respectively.
Differences in hormone concentrations over a feed
There was a signiﬁcant decrease in foremilk and hind-
milk ghrelin concentrations at 3 months postpartum.
Similarly, there appeared to be a trend towards a
Table 2 Descriptive characteristics of maternal and infant cohort
One week
postpartum
Three months
postpartum
Maternal
Number 105 92
Weight (kg) 70.3 (12.7) 66.5 (11.3)
Height (cm) 166 (6) 166 (6)
BMI (kg/m2) 25.4 (4.5) 23.9 (3.6)
University education (%) 85 89
Percentage of normal-weight women undergoing caesarean section 27%
Percentage of overweight/obese women undergoing caesarean section 46%
Infant
Weight (kg) 3.36 (0.44) 5.93 (0.85)
Length (cm) 50.9 (2.3) 61.3 (2.7)
Head circumference (cm) 35.2 (1.3) 40.3 (1.3)
Weight change birth to 7 days (kg) −0.05 (0.35)
Weight change 7 days to 3 months (kg) 2 (1.95)
Weight change birth to 3 months (kg) 1.97 (1.96)
Infant sex M/F 60 (57%), 45 (43%) 52 (56%), 40 (44%)
Data reported are means and SDs.
BMI, body mass index; F, female; M, male.
Table 3 Summary statistics for breast milk hormone concentrations
Stage of lactation: mean (SE) [n]
Type of milk 1 week 3 months p Value
Foremilk ghrelin (ng/mL) 123.0 (15.8) [96] 101.1 (11.5) [83] 0.17
Hindmilk ghrelin (ng/mL) 95.8 (16.9) [81] 59.3 (12.3) [66] 0.03
p Value 0.09 0.01
Foremilk insulin (ng/mL) 515.4 (42.4) [105] 524.8 (30.9) [92] 0.83
Hindmilk insulin (ng/mL) 439.5 (45.2) [91] 456.8 (32.9) [81] 0.70
p Value 0.08 0.13
Foremilk leptin (ng/mL) 541.7 (161.2) [105] 684.8 (117.4) [92] 0.38
Hindmilk leptin (ng/mL) 614.4 (172.1) [91] 464.3 (125.1) [81] 0.38
p Value 0.65 0.20
Foremilk resistin (ng/mL) 924.9 (295.9) [105] 792.5 (224.4) [92] 0.65
Hindmilk resistin (ng/mL) 967.4 (317.0) [91] 733.9 (238.9) [81] 0.46
p Value 0.89 0.85
p Values derived using repeated-measures ANOVA.
ANOVA, analysis of variance.
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decrease in the concentration of ghrelin in hindmilk in
samples collected at 1 week postpartum, but this did not
reach statistical signiﬁcance.
There appeared to be a trend towards reduced insulin
concentration in hindmilk samples in comparison with
foremilk at both time points (mean of both time points
(520.1 ng/mL in foremilk compared with 448.2 ng/mL
in hindmilk)).
Differences in hormone concentrations over lactation
Furthermore, there appeared to be a decrease in con-
centration of ghrelin in the samples collected at
3 months postpartum in comparison with samples col-
lected at 1 week postpartum, but this was only signiﬁcant
for the hindmilk samples collected (table 3). There
were no signiﬁcant associations between insulin concen-
trations of breast milk in relation to the time of sample
collection at either time point. Likewise, no relationship
was observed between the time of sample collection
and the concentration of leptin or resistin (table 3).
Also, the degree to which mothers breast fed, from
exclusively breast feeding to predominantly formula
feeding, was not observed to inﬂuence breast milk
hormone concentration.
Correlation between breast milk hormone concentration
and maternal BMI
Breast milk hormone concentrations were correlated
against maternal BMI at each time point, splitting
samples into fore and hind subgroups (table 4). One
mother was excluded from the analysis as her BMI was
extremely high in comparison with the rest of the
cohort (52.5 kg/m2), skewing the results. In foremilk at
1 week postpartum, this mother’s ghrelin, insulin, leptin
and resistin concentrations were 74.8, 309.7, 350.8 and
245.8 ng/mL, respectively. In the hindmilk sample,
these measurements changed to undetectable, 813.5,
200.4 and 9.2 ng/mL, respectively.
Breast milk ghrelin and resistin were not seen to correl-
ate with maternal BMI at either of the time points studied
(table 4). However, leptin concentrations in foremilk, but
not hindmilk, correlated with maternal BMI at 1 week
postpartum and 3 months postpartum. Furthermore,
insulin in foremilk at 3 months postpartum was seen to
correlate with maternal BMI.
Figure 1 displays the positive correlation between
maternal BMI and the log breast milk leptin concentra-
tion at 1 week post partum.
To establish whether non-linear associations between
the hormone concentrations and maternal BMI existed,
these variables were plotted against one another, sug-
gesting there were no non-linear associations between
Table 4 Correlations of maternal BMI with foremilk and hindmilk hormone concentrations at 1 week and 3 months postpartum
Ghrelin Insulin Leptin Resistin
Foremilk at 1 week
Spearman correlation −0.04 0.00 0.31 −0.04
Significance (two-tailed) 0.66 0.95 0.02 0.70
N 95 103 103 104
Hindmilk at 1 week
Spearman correlation 0.04 0.04 <0.00 −0.01
Significance (two-tailed) 0.73 0.74 0.96 0.90
N 81 90 90 89
Foremilk at 3 months
Spearman correlation 0.20 0.22 0.30 −0.01
Significance (two-tailed) 0.07 0.04 <0.00 0.87
N 83 92 92 91
Hindmilk at 3 months
Spearman correlation −0.06 −0.05 −0.04 −0.09
Significance (two-tailed) 0.61 0.63 0.72 0.45
N 66 81 81 79
BMI, body mass index.
Figure 1 Correlation at 1 week postpartum between breast
milk leptin concentrations and maternal BMI. Spearman
correlation coefficient 0.31, p=0.02. BMI, body mass index.
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maternal BMI and breast milk hormone concentration
(see online supplementary information, ﬁgure S1).
Maternal weight change from recruitment to 7 days
postpartum correlated with maternal BMI at recruitment
(Pearson correlation=0.22, signiﬁcance=0.04, n=86).
Correlations between maternal weight change and breast
milk hormone concentrations were also noted. Seven-day
hindmilk resistin correlated with maternal weight change
from 7 days to 3 months postpartum (Pearson correl-
ation=0.36, signiﬁcance=0.001, n=81). Also, 3-month fore-
milk leptin correlated with maternal weight change from
7 days to 3 months postpartum (Pearson correlation=0.25,
signiﬁcance=0.02, n=92), and 3-month foremilk insulin
concentrations and maternal weight change from 7 days
to 3 months postpartum were correlated (Pearson correl-
ation=0.28, signiﬁcance=0.01, n=81). No other correla-
tions were observed.
Table 5 shows the unadjusted values for the regression
analysis; adjusted values were almost identical. The asso-
ciation between leptin in foremilk and maternal BMI was
no longer signiﬁcant at the 7-day postpartum point in the
adjusted analysis; B=1.05 ng/mL, signiﬁcance=0.07, CI 1.00
to 1.11. However, the association between maternal BMI
and leptin in foremilk at 3 months postpartum remained
after adjustment; B=1.08 ng/mL, signiﬁcance=0.02, CI 1.01
to 1.14.
Correlations between breast milk hormone and
milk fat content
Also investigated were associations between breast milk
fat content, milk hormones and maternal BMI. No asso-
ciation between maternal BMI and fat concentration in
milk was observed; however, correlations between
fat content and breast milk hormone concentrations
were observed. In foremilk samples collected at 7 days
postpartum, insulin correlated with fat concentration
(Pearson correlation=0.23, signiﬁcance=0.03, n=92), while
leptin was seen to correlate with hindmilk fat concentra-
tion at 7 days postpartum (Pearson correlation=0.34, sig-
niﬁcance=0.03, n=40).
Correlations between breast milk hormone and
infant anthropometrics
Associations between infant anthropometric measure-
ments and breast milk hormone concentrations were
also investigated. No signiﬁcant associations were
observed between hormone concentrations in foremilk
samples collected at 1 week postpartum and infant
anthropometrics (weight, length, head circumference
and weight change between 7 days and 3 months).
Infant weight negatively correlated with insulin concen-
tration in hindmilk samples collected at 1 week post-
partum (Pearson correlation=−0.23, signiﬁcance=0.03,
n=90); no other associations were observed.
In foremilk samples collected at 3 months postpartum,
insulin was seen to negatively correlate with infant
length at 7 days postpartum (Pearson correlation=−0.21,
signiﬁcance=0.04, n=89); no other associations were
noted. No correlations were observed between infant
anthropometrics and hormone concentrations in hind-
milk samples collected at 3 months postpartum.
DISCUSSION
Each of the appetite-regulating hormones we studied
has previously been detected in breast milk.29–32 We pre-
viously conducted a systematic review and concluded
that the concentration of leptin is consistently increased
in the breast milk of overweight/obese women.33 Our
present study conﬁrms and extends this conclusion by
Table 5 Regression between foremilk and hindmilk hormone concentrations at 1 week and 3 months postpartum and
maternal BMI
Ghrelin Insulin Leptin Resistin
Time point Foremilk BMI at 1 week
B 0.99 (0.94 to 1.04) 1.00 (0.97 to 1.04) 1.05 (1.00 to 1.10) 0.98 (0.91 to 1.06)
Significance 0.55 0.79 0.05 0.65
N 95 103 103 104
Time point Hindmilk BMI at 1 week
B 1.00 (0.93 to 1.08) 1.00 (0.96 to 1.04) 1.01 (0.95 to 1.07) 0.98 (0.90 to 1.07)
Significance 0.88 0.89 0.72 0.70
N 81 90 90 89
Time point Foremilk BMI at 3 months
B 1.05 (0.99 to 1.11) 1.03 (0.99 to 1.07) 1.08 (1.02 to 1.16) 0.98 (0.90 to 1.07)
Significance 0.07 0.10 0.01 0.64
N 83 92 92 91
Time point Hindmilk BMI at 3 months
B 0.97 (0.90 to 1.05) 1.00 (0.96 to 1.04) 0.99 (0.92 to 1.06) 0.97 (0.89 to 1.06)
Significance 0.48 0.95 0.69 0.49
N 66 81 81 79
Natural log values used and antilogged.
BMI, body mass index.
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identifying a signiﬁcant association of maternal BMI
only with leptin in foremilk but not with hindmilk
leptin, at both time points studied.
Another novel observation is that resistin concentra-
tions remain stable over a feed. Differences were
observed in breast milk ghrelin concentrations in fore-
milk and hindmilk. Ghrelin was observed to decrease in
concentration from foremilk to hindmilk samples col-
lected at 3 months postpartum, with a similar trend
noted for the samples collected at 1 week postpartum,
similar to previous studies.21 Furthermore, a trend
towards reduced insulin concentrations in hindmilk
samples at both time points was observed. This study is
also in line with previous research suggesting that leptin
concentrations do not alter over a feed.20 21 These hor-
mones have been hypothesised to act as satiety factors,
inﬂuencing infant appetite over the course of a feed.20
Inconsistent ﬁndings in regard to the impact of mater-
nal BMI on the concentration of insulin in breast milk
have been reported, with two studies reporting a positive
correlation34 35 and two studies reporting no correlation
between the two.32 36 The present study seems to
support the ﬁndings of the two studies reporting no cor-
relation between maternal BMI and breast milk insulin
concentrations.
A previous study investigating the association between
the time of sample collection and breast milk ghrelin
concentrations found lower ghrelin concentrations in
samples collected earlier in lactation,37 not seen in the
present study. However, this comparison was made with
colostrum, which has a composition very different from
mature breast milk, and samples collected between 4
and 14 days were more comparable to samples collected
at 3 months postpartum. Three previous studies investi-
gating the association between maternal BMI and
ghrelin in breast milk found no association between the
two, a result conﬁrmed by our study.29 38 39
One study reporting the presence of resistin in breast
milk and its association with maternal BMI found no
correlation,31 a ﬁnding supported by the results of this
study. Also, the Savino et al study reported no associa-
tions between breast milk resistin and infant anthropo-
metrics, a ﬁnding strengthened by the results of this
study.
Infant weight was observed to negatively correlate with
the concentration of insulin in breast milk. This observa-
tion has been observed in a previous study by Fields and
Demerath,36 ﬁnding insulin concentrations were corre-
lated with lower lean, but not fat, mass. No correlations
between leptin concentration and infant anthropomet-
rics were observed in the present study. This is in con-
trast with previous studies reporting higher milk leptin
concentrations being associated with lower BMI Z-scores
and infant weight.26 36
To the best of our knowledge, this is the largest study
to date to describe the concentration of appetite-
regulating hormones in foremilk and hindmilk. Other
strengths include the longitudinal assessment of changes
of hormone concentrations. A further strength of this
study is the standardisation of sample collection to the
morning and the addition of protease inhibitor to
samples to protect against proteolytic degradation of the
peptide hormones.
Owing to the dropout of mothers, we did not meet
the number of participants recommended by the power
calculation to detect a correlation between insulin and
maternal BMI. This dropout reduced the power that the
study had to detect correlations between maternal BMI
and breast milk hormone concentrations, potentially
meaning correlations between these parameters have
gone undetected. In addition, the protease inhibitor was
not able to be added to samples immediately after col-
lection, only once they had been received in the labora-
tory, meaning some hormones may have been degraded.
Also, it would have been interesting to determine the
concentration of other appetite-regulating hormones in
this cohort, including adiponectin, which has previously
been shown to be associated with infant growth para-
meters (add reference). However, as adiponectin is
present in dramatically higher concentrations than the
other hormones analysed here, a separate test would
have to be performed, which we were unable to carry
out due to funding restraints. A further weakness in this
study is that we were unable to follow-up the infants to
establish whether there were any associations between
the concentrations of these hormones in breast milk
and the subsequent likelihood of infant overweight/
obesity.
Furthermore, using maternal BMI as a surrogate
marker for maternal adiposity may not be the most
appropriate measure during this time, as the mothers’
BMI was seen to be particularly variable over the post-
partum period. Indeed, a recent study employed dual
X-ray absorptiometry in order to more accurately assess
body composition.20
The ﬁndings presented here reﬂect previous literature
demonstrating overweight/obese mothers have difﬁculty
in maintaining breast feeding due to the increased
dropout of mothers with a higher BMI,40 as these
mothers were no longer breast feeding. Furthermore,
overweight/obese mothers were more likely to undergo
a caesarean section, putting women at a further disad-
vantage in successfully initiating early breast feeding, as
demonstrated by a meta-analysis where a negative associ-
ation between caesarean section and early breast
feeding was observed.41 The consequences of receiving
breast milk containing different concentrations of these
appetite-regulating hormones are unknown. The neo-
natal period has been identiﬁed as a critical period for
the programming of adult health,2 and this program-
ming may be partially mediated by hormones received
during this time.1 Indeed, several studies have identiﬁed
the associations between the concentration of these hor-
mones in breast milk and subsequent infant weight and
growth.25 26 42 However, these ﬁnding are associations
and may be explained by confounding factors.
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Once the effects of these appetite-regulating hor-
mones of infant physiology have been established, this
highlights the possibility of supplementing infant
formula with appropriate concentrations of these hor-
mones in order to improve outcomes for formula-fed
infants, particularly preterm infants. Indeed, insulin has
been added to formula milk in an attempt to promote
better growth, as well as to accelerate intestinal matur-
ation,43 the ultimate aim of which is to prevent later-life
diseases including allergy, autoimmune diseases and
obesity. However, before these bioactive factors can be
added to formula, assessment of their activities and
safety in clinical trials must be undertaken.
CONCLUSIONS
In conclusion, increasing maternal BMI is associated
with an increase in the concentration of leptin in breast
milk. The hormones insulin, ghrelin and resistin were
not observed to correlate with maternal BMI, suggesting
the concentrations of these hormones in breast milk are
regulated independently of maternal BMI, with other
factors determining their concentrations in breast milk.
Author affiliations
1Section of Neonatal Medicine, Department of Medicine, Chelsea &
Westminster Hospital Campus, Imperial College London, London, UK
2Parturition Research Group, Section of Academic Obstetrics & Gynaecology,
Department of Medicine, Chelsea & Westminster Hospital, Imperial College
London, London, UK
3Section of Computational and Systems Medicine, Faculty of Medicine,
Imperial College London, London, UK
Acknowledgements The authors would like to thank all the mothers and their
infants who took part in the study.
Contributors NJA, MJH, BRH and NM conceived and designed the
experiments. NJA and BRH performed the experiments. NJA, MJH, BRH, SS
and SM analysed the data. BRH contributed reagents/materials and analysis
tools. NJA, MJH, SJ, SS, EH and NM wrote the manuscript.
Funding This work was supported by Chelsea and Westminster Hospital Joint
Research Committee.
Competing interests NJA has received support from Medela to attend an
educational conference, but declared no other conflict of interest. MJH has
received support from Danone International to attend an educational
conference, but declared no other conflict of interest. In the past 5 years NM
has received consultancy fees from Ferring Pharmaceuticals and speaker
honorarium for an educational meeting funded by Nestle International.
Ethics approval West London (Fulham) Research Ethics Committee
(reference number 12/LO/0203).
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Raw data on hormone concentrations are freely
available upon request to n.modi@imperial.ac.uk.
Open Access This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
REFERENCES
1. Hamosh M. Bioactive factors in human milk. Pediatr Clin North Am
2001;48:69–86.
2. Lucas A. Long-term programming effects of early nutrition—
implications for the preterm infant. J Perinatol 2005;25(Suppl 2):
S2–6.
3. Agostoni C. Ghrelin, leptin and the neurometabolic axis of breastfed
and formula-fed infants. Acta Paediatr 2005;94:523–5.
4. Whitaker RC. Predicting preschooler obesity at birth: the role of
maternal obesity in early pregnancy. Pediatrics 2004;114:e29–36.
5. Considine RV, Sinha MK, Heiman ML, et al. Serum
immunoreactive-leptin concentrations in normal-weight and obese
humans. N Engl J Med 1996;334:292–5.
6. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin
(FIZZ3) protein is increased in obese humans. J Clin Endocrinol
Metab 2003;88:5452–5.
7. Lovejoy J, DiGirolamo M. Habitual dietary intake and insulin sensitivity
in lean and obese adults. Am J Clin Nutr 1992;55:1174–9.
8. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels
after diet-induced weight loss or gastric bypass surgery. N Engl J
Med 2002;346:1623–30.
9. Owen CG, Martin RM, Whincup PH, et al. Effect of infant feeding on
the risk of obesity across the life course: a quantitative review of
published evidence. Pediatrics 2005;115:1367–77.
10. Arenz S, Rückerl R, Koletzko B, et al. Breast-feeding and childhood
obesity–a systematic review. Int J Obes Relat Metab Disord
2004;28:1247–56.
11. Harder T, Bergmann R, Kallischnigg G, et al. Duration of
breastfeeding and risk of overweight: a meta-analysis. Am J
Epidemiol 2005;162:397–403.
12. Kramer MS, Chalmers B, Hodnett ED, et al. Promotion of
Breastfeeding Intervention Trial (PROBIT): a randomized trial in the
Republic of Belarus. JAMA 2001;285:413–20.
13. Smith-Kirwin SM, O’Connor DM, De Johnston J, et al. Leptin
expression in human mammary epithelial cells and breast milk.
J Clin Endocrinol Metab 1998;83:1810–13.
14. Lönnqvist F, Arner P, Nordfors L, et al. Overexpression of the obese
(ob) gene in adipose tissue of human obese subjects. Nat Med
1995;1:950–3.
15. Considine RV. Increased serum leptin indicates leptin resistance in
obesity. Clin Chem 2011;57:1461–2.
16. Kulski JK, Hartmann PE. Milk insulin, GH and TSH: relationship to
changes in milk lactose, glucose and protein during lactogenesis in
women. Endocrinol Exp 1983;17:317–26.
17. Pliquett RU, Führer D, Falk S, et al. The effects of insulin on the
central nervous system—focus on appetite regulation. Horm Metab
Res 2006;38:442–6.
18. Toshinai K, Yamaguchi H, Sun Y, et al. Des-acyl ghrelin induces
food intake by a mechanism independent of the growth hormone
secretagogue receptor. Endocrinology 2006;147:2306–14.
19. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links
obesity to diabetes. Nature 2001;409:307–12.
20. Schueler J, Alexander B, Hart AM. Presence and dynamics of leptin,
GLP-1, and PYY in human breast milk at early postpartum. Obesity
(Silver Spring) 2013;21:1451–8.
21. Karatas Z, Durmus Aydogdu S, Dinleyici EC, et al. Breastmilk
ghrelin, leptin, and fat levels changing foremilk to hindmilk: is that
important for self-control of feeding? Eur J Pediatr
2011;170:1273–80.
22. Ilcol YO, Hizli BZ. Leptin concentration in human breast milk and its
relationship to hormonal status. Clin Chem 2006;52:A91–A91.
23. Ilcol YO, Hizli B. Active and total ghrelin concentrations increase in
breast milk during lactation. Acta Paediatr 2007;96:1632–9.
24. Casabiell X, Piñeiro V, Tomé MA, et al. Presence of leptin in
colostrum and/or breast milk from lactating mothers: a potential role
in the regulation of neonatal food intake. J Clin Endocrinol Metab
1997;82:4270–3.
25. Doneray H, Orbak Z, Yildiz L. The relationship between breast milk
leptin and neonatal weight gain. Acta Paediatr 2009;98:643–7.
26. Miralles O, Sánchez J, Palou A, et al. A physiological role of breast
milk leptin in body weight control in developing infants. Obesity
(Silver Spring) 2006;14:1371–7.
27. Hirsová D, Koldovský O. On the question of the absorption of insulin
from the gastrointestinal tract during postnatal development. Physiol
Bohemoslov 1969;18:281–4.
28. Plagemann A, Harder T, Franke K, et al. Long-term impact of
neonatal breast-feeding on body weight and glucose tolerance
in children of diabetic mothers. Diabetes Care 2002;25:16–22.
29. Aydin S, Ozkan Y, Kumru S. Ghrelin is present in human colostrum,
transitional and mature milk. Peptides 2006;27:878–82.
30. Houseknecht KL, McGuire MK, Portocarrero CP, et al. Leptin is
present in human milk and is related to maternal plasma leptin
concentration and adiposity. Biochem Biophys Res Commun
1997;240:742–7.
8 Andreas NJ, et al. BMJ Open 2016;6:e010778. doi:10.1136/bmjopen-2015-010778
Open Access
group.bmj.com on July 8, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
31. Savino F, Sorrenti M, Benetti S, et al. Resistin and leptin in breast
milk and infants in early life. Early Hum Dev 2012;88:779–82.
32. Shehadeh N, Khaesh-Goldberg E, Shamir R, et al. Insulin in human
milk: postpartum changes and effect of gestational age. Arch Dis
Child Fetal Neonatal Ed 2003;88:F214–16.
33. Andreas NJ, Hyde MJ, Gale C, et al. Effect of maternal body mass
index on hormones in breast milk: a systematic review. PLoS ONE
2014;9:e115043.
34. Ahuja S, Boylan M, Hart SL. Glucose and insulin levels are increased in
obese and overweight mothers’ breast-milk. Food Nutr Sci 2011;2:201–6.
35. Ley SH, Hanley AJ, Sermer M, et al. Associations of prenatal
metabolic abnormalities with insulin and adiponectin concentrations
in human milk. Am J Clin Nutr 2012;95:867–74.
36. Fields DA, Demerath EW. Relationship of insulin, glucose, leptin,
IL-6 and TNF-α in human breast milk with infant growth and body
composition. Pediatr Obes 2012;7:304–12.
37. Ilcol YO, Hizli ZB, Eroz E. Resistin is present in human breast milk
and it correlates with maternal hormonal status and serum level of
C-reactive protein. Clin Chem Lab Med 2008;46:118–24.
38. Aydin S. The presence of the peptides apelin, ghrelin and
nesfatin-1 in the human breast milk, and the lowering of their levels
in patients with gestational diabetes mellitus. Peptides
2010;31:2236–40.
39. Aydin S, Geckil H, Karatas F, et al. Milk and blood ghrelin level in
diabetics. Nutrition 2007;23:807–11.
40. Lepe M, Bacardí Gascón M, Castañeda-González LM, et al. Effect
of maternal obesity on lactation: systematic review. Nutr Hosp
2011;26:1266–9.
41. Prior E, Santhakumaran S, Gale C, et al. Breastfeeding after
cesarean delivery: a systematic review and meta-analysis of world
literature. Am J Clin Nutr 2012;95:1113–35.
42. Khodabakhshi A, Ghayour-Mobarhan M, Rooki H, et al. Comparative
measurement of ghrelin, leptin, adiponectin, EGF and IGF-1 in
breast milk of mothers with overweight/obese and normal-weight
infants. Eur J Clin Nutr 2015;69:614–18.
43. Shamir R, Shehadeh N. Insulin in human milk and the use of
hormones in infant formulas. Nestle Nutr Inst Workshop Ser
2013;77:57–64.
Andreas NJ, et al. BMJ Open 2016;6:e010778. doi:10.1136/bmjopen-2015-010778 9
Open Access
group.bmj.com on July 8, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
study
across a single feed: a longitudinal cohort 
insulin, ghrelin and resistin in breast milk
strategy on the concentration of leptin, 
Impact of maternal BMI and sampling
Modi
Shalini Santhakumaran, Sundhiya Mandalia, Elaine Holmes and Neena 
Nicholas J Andreas, Matthew J Hyde, Bronwen R Herbert, Suzan Jeffries,
doi: 10.1136/bmjopen-2015-010778
2016 6: BMJ Open 
 http://bmjopen.bmj.com/content/6/7/e010778
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/6/7/e010778
This article cites 43 articles, 9 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by/4.0/
use, provided the original work is properly cited. See: 
others to distribute, remix, adapt and build upon this work, for commercial
the Creative Commons Attribution (CC BY 4.0) license, which permits 
This is an Open Access article distributed in accordance with the terms of
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (449)Paediatrics
 (231)Nutrition and metabolism
 (297)Diabetes and Endocrinology
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on July 8, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
